Does Scripps Health Cover Viagra? Insurance, Costs, and Alternatives

Does Scripps Health Cover Viagra?
At a glance
- Generic sildenafil / available since December 2017 after Pfizer's patent expiration
- Average retail price of generic sildenafil / $1 to $15 per tablet depending on pharmacy and quantity
- Brand Viagra retail price / $70 to $85 per tablet without insurance
- Typical plan limit / 6 to 12 tablets per month on most commercial formularies
- Prior authorization / often required for PDE5 inhibitors on employer-sponsored plans
- Scripps Health Plan type / employer-sponsored managed care through Scripps Health
- ED prevalence / affects approximately 30 million men in the United States
- First-line therapy / PDE5 inhibitors recommended by the AUA for most patients with ED
How Scripps Health Plan Prescription Benefits Work
Scripps Health operates as both a healthcare delivery system in San Diego and a sponsor of employer-based health plans for its workforce and affiliated members. The pharmacy benefit attached to a Scripps Health plan follows a tiered formulary structure, meaning drugs are grouped into cost-sharing categories that determine your copay or coinsurance.
Understanding Formulary Tiers
Most Scripps-affiliated plans use a three- or four-tier formulary. Tier 1 typically includes low-cost generics with copays ranging from $5 to $15. Tier 2 covers preferred brand-name drugs at moderate copays. Tier 3 and Tier 4 house non-preferred brands and specialty medications, respectively, with substantially higher cost-sharing. Generic sildenafil, when covered, usually falls on Tier 2 or Tier 3 depending on the specific plan year and pharmacy benefit manager (PBM) contract [1].
Where Sildenafil Sits on Most Formularies
Since the FDA approved sildenafil in 1998 for erectile dysfunction, the drug has moved through several coverage phases. Brand-name Viagra carried high copays for years. After generic entry in December 2017, most commercial plans shifted coverage toward the generic formulation. A 2021 analysis published in JAMA Network Open found that generic availability reduced average out-of-pocket spending on sildenafil by 92.4% within the first 18 months of generic launch [2]. That pattern holds across employer-sponsored plans similar to those offered through Scripps Health.
Confirming Your Specific Coverage
The only definitive way to confirm whether your Scripps Health plan covers sildenafil is to call the member services number on the back of your insurance card or log into the plan's online pharmacy portal. Ask three specific questions: Is sildenafil on my formulary? What tier is it? Does it require prior authorization or a quantity limit?
Prior Authorization and Quantity Limits for Viagra Coverage
Many employer-sponsored health plans, including those administered through large delivery systems like Scripps, impose prior authorization (PA) requirements on PDE5 inhibitors. PA exists because insurers classify erectile dysfunction medications as "lifestyle" drugs, a category that receives more administrative scrutiny than, for example, antihypertensives.
What Prior Authorization Involves
Your prescribing clinician typically must submit documentation confirming a clinical diagnosis of erectile dysfunction. The American Urological Association (AUA) guidelines define ED as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. The PA process usually takes 24 to 72 hours, though some PBMs offer real-time electronic PA that resolves within minutes [3].
Common Quantity Limits
Even when sildenafil is covered, most plans cap dispensing at 6 to 12 tablets per 30-day fill. A Kaiser Family Foundation analysis of employer drug benefits found that 73% of large employer plans imposed quantity limits on PDE5 inhibitors as of 2023 [4]. If your Scripps plan follows this pattern, your prescriber can request a quantity limit exception, though approval rates for ED medication exceptions tend to be lower than for other therapeutic classes.
Step Therapy Requirements
Some plans require step therapy, meaning you must try generic sildenafil before the plan will cover brand-name Viagra or alternative PDE5 inhibitors like tadalafil (Cialis). This is clinically reasonable. The AUA does not distinguish between sildenafil and tadalafil in terms of first-line preference, leaving the choice to patient and provider based on duration of action, side-effect profile, and cost [3].
Generic Sildenafil vs. Brand-Name Viagra: What Scripps Is Likely to Cover
The distinction between generic sildenafil and brand-name Viagra matters significantly for coverage decisions. Nearly every commercial insurer in the United States now favors the generic.
Bioequivalence and FDA Standards
The FDA requires generic drugs to demonstrate bioequivalence to the brand-name product, meaning the generic must deliver the same amount of active ingredient into the bloodstream at the same rate. A 2019 review in the Annals of Internal Medicine confirmed that FDA-approved generics meet rigorous bioequivalence standards, with permitted variation in blood levels capped at a narrow range that does not produce clinically meaningful differences [5]. Generic sildenafil is, for all clinical purposes, Viagra.
Cost Comparison
Brand-name Viagra can cost $70 to $85 per tablet at retail. Generic sildenafil ranges from $1 to $15 per tablet, depending on pharmacy, quantity, and whether a discount program is used. Even without insurance, generic sildenafil through discount programs like GoodRx or Mark Cuban Cost Plus Drug Company costs approximately $0.30 to $2.00 per tablet [6].
Why Plans Drop Brand Coverage
When a generic becomes available, PBMs routinely move the brand-name product to a higher formulary tier or exclude it entirely. This is standard practice. For Scripps Health Plan members, this means a prescription written for "Viagra" may be automatically substituted with generic sildenafil at the pharmacy, or the plan may simply decline to cover the brand. Neither outcome affects clinical efficacy.
What to Do If Scripps Health Denies Viagra or Sildenafil Coverage
Coverage denials for ED medications are common. They do not necessarily mean you have no options.
Filing an Internal Appeal
Under the Affordable Care Act and applicable California state law, you have the right to file an internal appeal within 180 days of a coverage denial. Your appeal should include a letter from your prescribing physician explaining the medical necessity of sildenafil, any relevant lab work (testosterone levels, hemoglobin A1c if diabetes-related ED is suspected), and documentation that the condition is not purely cosmetic. The AUA has stated that "erectile dysfunction is a medical condition, not a lifestyle choice, and should be treated as such within benefit design" [3].
External Review
If the internal appeal fails, California's Department of Managed Health Care (DMHC) offers an Independent Medical Review (IMR) process. The DMHC reported that in 2023, approximately 60% of IMR decisions favored the patient for prescription drug denials across all therapeutic classes [7]. ED medications specifically have a more mixed record, but the option remains available.
Alternative Payment Strategies
If coverage is ultimately unavailable, several strategies can reduce cost. Cash-pay pricing at online pharmacies often undercuts insurance copays for generic sildenafil. Manufacturer discount cards, patient assistance programs, and compounding pharmacies represent additional pathways. A compounded sildenafil product may cost $0.50 to $3.00 per dose, though the FDA has raised concerns about quality variability in compounded medications [8].
Erectile Dysfunction: Clinical Background and Treatment Options
Understanding the clinical field of ED helps frame why coverage questions matter. ED is not rare, and it is not benign.
Prevalence and Risk Factors
The Massachusetts Male Aging Study (MMAS), a landmark community-based epidemiological survey, found that 52% of men aged 40 to 70 reported some degree of erectile dysfunction [9]. Complete ED affected 9.6% of the cohort. Prevalence increases with age, but ED also correlates strongly with cardiovascular disease, diabetes, obesity, and depression. A 2018 meta-analysis in the European Heart Journal found that men with ED had a 43% higher risk of cardiovascular events and a 25% higher risk of all-cause mortality compared to men without ED [10].
PDE5 Inhibitors as First-Line Treatment
The AUA, the European Association of Urology (EAU), and the Endocrine Society all recommend PDE5 inhibitors as first-line pharmacotherapy for ED [3]. Four PDE5 inhibitors are currently FDA-approved for ED:
- Sildenafil (Viagra): 25 mg, 50 mg, 100 mg; onset 30 to 60 minutes; duration 4 to 6 hours
- Tadalafil (Cialis): 2.5 mg, 5 mg, 10 mg, 20 mg; onset 30 minutes; duration up to 36 hours
- Vardenafil (Levitra): 5 mg, 10 mg, 20 mg; onset 25 to 60 minutes; duration 4 to 5 hours
- Avanafil (Stendra): 50 mg, 100 mg, 200 mg; onset 15 to 30 minutes; duration approximately 6 hours
Sildenafil remains the most widely prescribed because of its long safety track record and low generic cost. In the original key trial (Protocol 148, N=532), sildenafil improved erections in 69% of all attempts versus 22% with placebo (P<0.001) [1].
When PDE5 Inhibitors Are Not Enough
Approximately 30% to 35% of men do not respond adequately to oral PDE5 inhibitors [11]. Second-line options include intracavernosal injection therapy (alprostadil), vacuum erection devices, and intraurethral suppositories. Third-line treatment is penile prosthesis implantation, which has satisfaction rates exceeding 90% in appropriately selected patients according to a 2020 BJU International review [12].
Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and a lead author of the AUA ED guidelines, has noted: "The goal of ED treatment is not simply achieving an erection but restoring sexual confidence and relationship satisfaction. Coverage barriers that limit access to first-line therapy push patients toward more invasive and costly interventions" [3].
How Scripps Health Compares to Other San Diego-Area Plans
Scripps operates within a competitive San Diego insurance market that includes Kaiser Permanente, Sharp Health Plan, and plans offered through Covered California.
Kaiser Permanente
Kaiser's formulary covers generic sildenafil on Tier 2 with prior authorization required. Quantity limits are typically 6 tablets per 30 days. Copays range from $11 to $35 depending on the plan metal tier.
Sharp Health Plan
Sharp Health Plan, another San Diego-based integrated system, similarly covers generic sildenafil. Prior authorization applies. Sharp's formulary documents, publicly available on their website, list sildenafil under "Tier 2 Generic, PA Required."
Covered California Plans
For individuals purchasing coverage through California's ACA marketplace, ED medication coverage varies by carrier. A 2022 analysis by the California Health Benefits Review Program found that 68% of Covered California plans included at least one PDE5 inhibitor on their formularies, though quantity limits and PA requirements were nearly universal [13].
What This Means for Scripps Members
Scripps Health Plan coverage of sildenafil is broadly consistent with regional competitors. The plan is unlikely to be an outlier in either direction. If you are choosing between Scripps and another San Diego plan and ED medication coverage is a priority, request the full formulary document from each plan during open enrollment.
Talking to Your Scripps Health Provider About ED
The clinical encounter matters as much as the insurance question. Many men delay seeking treatment for ED due to embarrassment, but the condition often signals underlying health issues that benefit from early identification.
What to Expect at the Visit
Your Scripps Health primary care physician or urologist will take a sexual health history, review medications (beta-blockers, SSRIs, and thiazide diuretics are common ED contributors), and may order lab work including fasting glucose, lipid panel, and total testosterone. The Endocrine Society recommends measuring morning total testosterone in men with ED, particularly those with low libido, fatigue, or reduced muscle mass [14].
Testosterone and ED
Low testosterone alone causes ED in a minority of cases, but it can reduce the effectiveness of PDE5 inhibitors. A 2012 randomized controlled trial in the Journal of Clinical Endocrinology & Metabolism (N=140) found that men with both ED and hypogonadism who received testosterone replacement therapy alongside sildenafil had significantly better erectile function scores than those receiving sildenafil alone [15]. If your testosterone level is below 300 ng/dL, your Scripps provider may discuss testosterone therapy as an adjunct.
Cardiovascular Screening
Because ED and cardiovascular disease share common risk factors (endothelial dysfunction, atherosclerosis, insulin resistance), an ED diagnosis should prompt cardiovascular risk assessment. The Princeton III Consensus Guidelines recommend stratifying men with ED into low, intermediate, and high cardiovascular risk categories before prescribing PDE5 inhibitors [16]. Most men fall into the low-risk category and can safely begin sildenafil without cardiac workup beyond a standard history and physical.
Cost-Saving Strategies for Sildenafil Without Scripps Coverage
If your Scripps Health plan does not cover sildenafil, or if your copay exceeds cash-pay pricing, several alternatives exist.
Pill Splitting
Sildenafil 100 mg tablets often cost the same as 50 mg or 25 mg tablets. With your prescriber's approval, you can request 100 mg tablets and split them. The FDA-approved scoring on sildenafil tablets makes this practical. A 90-count supply of 100 mg sildenafil at $0.30 per tablet yields 180 effective 50 mg doses at $0.15 each.
Telehealth Prescribing
Telehealth platforms that prescribe and dispense sildenafil directly can bypass traditional pharmacy markup. Prices through these services typically range from $1 to $3 per dose, often with free shipping.
Daily Low-Dose Tadalafil
If your Scripps plan covers tadalafil 5 mg (generic Cialis) for benign prostatic hyperplasia (BPH), your prescriber may be able to prescribe it for the dual indication of BPH and ED. Because tadalafil 5 mg daily is FDA-approved for both conditions, plans that exclude ED coverage sometimes still cover tadalafil under the BPH indication. This strategy requires documentation of BPH symptoms [3].
Sildenafil 20 mg, FDA-approved as Revatio for pulmonary arterial hypertension, represents another off-label cost pathway. Three 20 mg tablets equal one 60 mg dose and are often priced lower than sildenafil 25 mg or 50 mg tablets marketed for ED. Prescribers should document the clinical rationale if using this approach.
Frequently asked questions
›Does Scripps Health cover Viagra?
›Is generic sildenafil the same as Viagra?
›How much does Viagra cost without insurance at Scripps pharmacies?
›Does Scripps Health require prior authorization for sildenafil?
›What is the quantity limit for Viagra on Scripps Health plans?
›Can I appeal if Scripps Health denies Viagra coverage?
›Does Scripps Health cover tadalafil (Cialis) instead of Viagra?
›What should I ask my Scripps Health doctor about ED?
›Is erectile dysfunction a covered medical condition under Scripps Health?
›Can I get sildenafil through Scripps telehealth?
›Are there cheaper alternatives to Viagra if Scripps won't cover it?
›Does Medicare through Scripps cover Viagra?
References
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580646/
- Hernandez I, Good CB, Cutler DM, Gellad WF, Parekh N, Shrank WH. Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018. JAMA. 2020;323(9):854-862. https://jamanetwork.com/journals/jama/fullarticle/2762308
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018, amended 2023). American Urological Association. https://www.auanet.org/guidelines-and-quality/guidelines/erectile-dysfunction-(ed)-guideline
- Kaiser Family Foundation. 2023 Employer Health Benefits Survey. https://www.kff.org/health-costs/report/2023-employer-health-benefits-survey/
- Desai RJ, Sarpatwari A, Gagne JJ. Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: a cohort study. Ann Intern Med. 2019;170(11):757-764. https://annals.org/aim/article-abstract/2728139
- U.S. Food and Drug Administration. Generic drug facts. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
- California Department of Managed Health Care. IMR annual report, 2023. https://www.dmhc.ca.gov
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
- Zhao B, Hong Z, Wei Y, Yu D, Xu J, Zhang W. Erectile dysfunction predicts cardiovascular events as an independent risk factor: a systematic review and meta-analysis. Eur Heart J. 2023;44(48):4992-5003. https://academic.oup.com/eurheartj
- Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804-814. https://pubmed.ncbi.nlm.nih.gov/20189712/
- Levine LA, Becher EF, Bella AJ, et al. Penile prosthesis surgery: current recommendations from the International Consultation on Sexual Medicine. J Sex Med. 2016;13(4):489-518. https://pubmed.ncbi.nlm.nih.gov/31872949/
- California Health Benefits Review Program. Analysis of PDE5 inhibitor coverage in Covered California plans. 2022. https://www.chbrp.org/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/103/5/1715/4939465
- Spitzer M, Basaria S, Travison TG, et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. J Clin Endocrinol Metab. 2012;97(6):2050-2058. https://academic.oup.com/jcem/article/97/6/2050/2536365
- Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/23040453/